Literature DB >> 11513485

Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801.

S Oh1, Y H Kim, H J Hann, H L Lee, H S Choi, H S Kim, I K Ho.   

Abstract

The effects of continuous infusion of NMDA receptor antagonist MK-801 on the modulation of NMDA receptor subunits NR1, NR2A, NR2B, and NR2C were investigated by using in situ hybridization study. Differential assembly of NMDA receptor subunits determines their functional characteristics. Continuous intracerebroventricular (i.c.v.) infusion with MK-801 (1 pmol/10 microl/h) for 7 days resulted in significant modulations in the NR1, NR2A, and NR2B mRNA levels without producing stereotypic motor syndromes. The levels of NR1 mRNA were significantly increased (9-20%) in the cerebral cortex, striatum, septum, and CA1 of hippocampus in MK-801-infused rats. The levels of NR2A mRNA were significantly decreased (11-16%) in the CA3 and dentate gyrus of hippocampus in MK-801-infused rats. In contrast to NR2A, NR2B subunit mRNA levels were increased (10-14%) in the cerebral cortex, caudate putamen, and thalamus. However, no changes of NR2C subunits in cerebellar granule layer were observed. Using quantitative ligand autoradiography, the binding of NMDA receptor ligand [3H]MK-801 was increased (12-25%) significantly in almost all brain regions except in the thalamus and cerebellum after 7 days infusion with MK-801. These results suggest that region-specific changes of NMDA receptor subunit mRNA and [3H]MK-801 binding are involved in the MK-801-infused adult rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513485     DOI: 10.1023/a:1010977315838

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Endogenous extracellular glutamate accumulation in rat neocortical cultures by reversal of the transmembrane sodium gradient.

Authors:  C P Taylor; J J Geer; S P Burke
Journal:  Neurosci Lett       Date:  1992-10-12       Impact factor: 3.046

2.  MK-801 alters the GABAA receptor complex and potentiates flurazepam's antiseizure efficacy.

Authors:  S I Deutsch; C H Park; L G Lukacs; C Morn; L Koetzner; J Mastropaolo
Journal:  Pharmacol Biochem Behav       Date:  1995-08       Impact factor: 3.533

3.  Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex.

Authors:  R Sircar; P Follesa; M K Ticku
Journal:  Brain Res Mol Brain Res       Date:  1996-09-01

4.  Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.

Authors:  T Ishii; K Moriyoshi; H Sugihara; K Sakurada; H Kadotani; M Yokoi; C Akazawa; R Shigemoto; N Mizuno; M Masu
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

5.  Role of NMDA receptors in pentobarbital tolerance/dependence.

Authors:  S Oh; K Hoshi; I K Ho
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

6.  Ethanol withdrawal seizures and the NMDA receptor complex.

Authors:  K A Grant; P Valverius; M Hudspith; B Tabakoff
Journal:  Eur J Pharmacol       Date:  1990-02-13       Impact factor: 4.432

7.  Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

Authors:  T Nishikawa; M Takashima; M Toru
Journal:  Neurosci Lett       Date:  1983-10-10       Impact factor: 3.046

Review 8.  Excitatory amino acid receptors, excitotoxicity, and the human nervous system.

Authors:  P J Shaw
Journal:  Curr Opin Neurol Neurosurg       Date:  1993-06

9.  Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions.

Authors:  P J Roberts; S D Anderson
Journal:  J Neurochem       Date:  1979-05       Impact factor: 5.372

10.  The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.

Authors:  A L Buller; H C Larson; B E Schneider; J A Beaton; R A Morrisett; D T Monaghan
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

View more
  6 in total

Review 1.  Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function.

Authors:  Ana Sanchez-Perez; Marta Llansola; Omar Cauli; Vicente Felipo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

2.  Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats.

Authors:  Richard M Allen; Linda A Dykstra; Regina M Carelli
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

3.  Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats.

Authors:  Richard M Allen; Kristina A Uban; Elizabeth M Atwood; David S Albeck; Dorothy J Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-07-21       Impact factor: 3.533

4.  Continuous exposure to dizocilpine facilitates escalation of cocaine consumption in male Sprague-Dawley rats.

Authors:  Richard M Allen
Journal:  Drug Alcohol Depend       Date:  2013-09-14       Impact factor: 4.492

5.  Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons.

Authors:  L K Nilsson; K R Linderholm; S Erhardt
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.850

6.  Chronic MK-801 Application in Adolescence and Early Adulthood: A Spatial Working Memory Deficit in Adult Long-Evans Rats But No Changes in the Hippocampal NMDA Receptor Subunits.

Authors:  Libor Uttl; Tomas Petrasek; Hilal Sengul; Marketa Svojanovska; Veronika Lobellova; Karel Vales; Dominika Radostova; Grygoriy Tsenov; Hana Kubova; Anna Mikulecka; Jan Svoboda; Ales Stuchlik
Journal:  Front Pharmacol       Date:  2018-02-12       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.